Riskpilot← Back to searchSign inGet full accessNORDIC NEUROTECH AS
ASActiveOrg 919892854Stenersgata 1A, 0050 OsloComputer programming activities · NACE 6210Est. 20170 employees
Revenue 2021
NOK 1,9M
-64% vs 2020
EBITDA margin
-255.6%
-303% vs 2020
Equity ratio
85.1%
Financial strength
Net profit 2021
NOK -5,1M
-343% vs 2020
| Revenue | NOK 1,9M | -64% |
| EBITDA | NOK -4,9M | -303% |
| Net profit | NOK -5,1M | -343% |
| Total assets | NOK 6,5M | -43% |
| Equity | NOK 5,6M | -48% |
| Employees | 0 | — |
Legal name
NORDIC NEUROTECH AS
Org number
919892854
Legal form
Aksjeselskap
NACE code
6210 · Computer programming activities
Founded
13. november 2017
Share capital
NOK 45 922
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Company purpose
Å skape innovative vr/ar/mr løsninger for privatmarkedet, bedrifter og organisasjoner nasjonalt og internasjonalt. Være oppdatert og godt synlig gjennom gode løsninger på det nasjonale og internasjonale markedet, samt holde foredrag og jobbe med konsulent virksomhet innenfor området.
Address
Stenersgata 1A, 0050 Oslo
Phone
+4796682344
Email
contact@vrgames.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Revenue | 163 | 618 | 5 292 | 1 927 |
| Staff expenses | −6 | −1 019 | −1 680 | −3 629 |
| EBITDA | −37 | −1 098 | 2 432 | −4 925 |
| Depreciation & amort. | −0 | −75 | −96 | −137 |
| EBIT | −37 | −1 173 | 2 336 | −5 062 |
| Net financials | 0 | −40 | −5 | 1 |
| Profit before tax | −37 | −1 213 | 2 331 | −5 061 |
| Tax | −0 | −0 | 246 | −0 |
| Net profit | −37 | −1 213 | 2 085 | −5 061 |
| Item | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Total assets | 227 | 407 | 11 444 | 6 527 |
| Equity | −7 | −1 220 | 10 613 | 5 551 |
| Long-term debt | 250 | 1 170 | 32 | 55 |
| Short-term debt | −16 | 457 | 800 | 920 |
| Total debt | 234 | 1 627 | 831 | 975 |
EBITDA margin
-255.6%
This company
15.8%
Market median
-1718% vs market
20182021
Equity ratio
85.1%
This company
38.2%
Market median
+123% vs market
20182021
Return on equity
-91.2%
This company
18.4%
Market median
-596% vs market
20182021
Net profit margin
-262.6%
This company
8.1%
Market median
-3342% vs market
20182021
Asset turnover
0.30×
This company
1.12×
Market median
-73% vs market
20182021
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
20182021
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KL Chief Executive Officer | Chief Executive Officer | 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 68.75% | 68.75% | 2022 | |
| Company | 24.9% | 24.9% | 2022 | |
| Individual | 2.07% | 2.07% | 2022 | |
| Individual | 1.31% | 1.31% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
The Nod As
NORDIC NEUROTECH AS Board members of NORDIC NEUROTECH AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kim Lien | Chief Executive Officer | 0 companies |
| Karl Arne Johannessen | Board of Directors | 0 companies |
| John Maxfield Steineger | Chairman | 0 companies |